Table 3 Multivariate prognostic factor analysis for PFS and OS
HR (95 % CI) | p-value | |
|---|---|---|
Progression-free survival | ||
ECOG PS, 1/2 vs. 0 | 1.94 (1.31-2.89) | 0.001 |
CA19.9, ≥157 U/ml vs. <157 U/ml | 1.58 (1.08-2.33) | 0.019 |
Gender, female vs. male | 1.49 (1.04-2.14) | 0.028 |
Lung metastases, yes vs. no | 1.48 (1.02-2.14) | 0.040 |
Overall survival | ||
ECOG PS, 1/2 vs. 0 | 3.56 (2.25-5.61) | <0.001 |
Stage, metastatic vs. locally advanced | 3.25 (1.58-6.69) | 0.001 |
CA19.9, ≥157 U/ml vs. <157 U/ml | 1.96 (1.25-3.05) | 0.003 |